Clinical advantages of new peritoneal dialysis solutions.
A review is given of the various mechanisms by which conventional glucose/lactate-based peritoneal dialysis solutions can induce damage to the peritoneal membrane. The potential advantages of newly developed dialysis solutions and the results of recent studies on their use in patients are discussed.
Krediet
Raymond T
RT
Division of Nephrology, Department of Medicine, Academic Medical Centre University of Amsterdam, Amsterdam, The Netherlands.
van Westrhenen
Roos
R
Zweers
Machteld M
MM
Struijk
Dirk G
DG
D000596:Amino Acids; D001639:Bicarbonates; D015314:Dialysis Solutions / Q000737:chemistry*; D005936:Glucans; D005947:Glucose / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D000077607:Icodextrin; D019344:Lactic Acid; D010530:Peritoneal Dialysis
D000596:Amino Acids; D001639:Bicarbonates; D015314:Dialysis Solutions; D005936:Glucans; D000077607:Icodextrin; D019344:Lactic Acid; D005947:Glucose